# Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)

> clinical trial · VERIFIED · 2026-07-20

Status: COMPLETED · Sponsor: Chiesi Farmaceutici S.p.A. · Condition: COPD (Chronic Obstructive Pulmonary Disease)

- Company: Chiesi Farmaceutici S.p.A.
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT03197818

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.